FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1830-1832 June 23, 1994 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Chodak, G. W. PubMed Citation

To the Editor: Chodak et al. (Jan. 27 issue)¹ conclude that conservative management is an appropriate choice for some patients with clinically localized prostate cancer -- that is, those with a life expectancy of 10 years or less. However, because they did not detect a statistically significant bias due to the overrepresentation of men with low-grade, low-stage tumors in their patient population, Chodak et al. imply that conservative management is appropriate for all patients with localized prostate cancer.

In their sample of patients, the risk ratios for mortality due to prostate cancer increased proportionately, albeit not always significantly, with tumor . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Woolf, S. H. (1995). Screening for Prostate Cancer with Prostate-Specific Antigen -- An Examination of the Evidence. NEJM 333: 1401-1405 [Full Text]